20505094|t|Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
20505094|a|Alzheimer's disease (AD), the most prevalent age-related neurodegenerative disorder, is characterized pathologically by the accumulation of beta-amyloid (Abeta) plaques and tau-laden neurofibrillary tangles. Interestingly, up to 50% of AD cases exhibit a third prevalent neuropathology: the aggregation of alpha-synuclein into Lewy bodies. Importantly, the presence of Lewy body pathology in AD is associated with a more aggressive disease course and accelerated cognitive dysfunction. Thus, Abeta, tau, and alpha-synuclein may interact synergistically to promote the accumulation of each other. In this study, we used a genetic approach to generate a model that exhibits the combined pathologies of AD and dementia with Lewy bodies (DLB). To achieve this goal, we introduced a mutant human alpha-synuclein transgene into 3xTg-AD mice. As occurs in human disease, transgenic mice that develop both DLB and AD pathologies (DLB-AD mice) exhibit accelerated cognitive decline associated with a dramatic enhancement of Abeta, tau, and alpha-synuclein pathologies. Our findings also provide additional evidence that the accumulation of alpha-synuclein alone can significantly disrupt cognition. Together, our data support the notion that Abeta, tau, and alpha-synuclein interact in vivo to promote the aggregation and accumulation of each other and accelerate cognitive dysfunction.
20505094	33	38	Abeta	Gene	11820
20505094	40	43	tau	Gene	4137
20505094	49	64	alpha-synuclein	Gene	20617
20505094	101	118	cognitive decline	Disease	MESH:D003072
20505094	120	139	Alzheimer's disease	Disease	MESH:D000544
20505094	141	143	AD	Disease	MESH:D000544
20505094	165	203	age-related neurodegenerative disorder	Disease	MESH:D019636
20505094	274	279	Abeta	Gene	351
20505094	293	296	tau	Gene	4137
20505094	303	326	neurofibrillary tangles	Disease	MESH:D055956
20505094	356	358	AD	Disease	MESH:D000544
20505094	426	441	alpha-synuclein	Gene	6622
20505094	447	458	Lewy bodies	Disease	MESH:D020961
20505094	489	508	Lewy body pathology	Disease	MESH:D020961
20505094	512	514	AD	Disease	MESH:D000544
20505094	583	604	cognitive dysfunction	Disease	MESH:D003072
20505094	612	617	Abeta	Gene	351
20505094	619	622	tau	Gene	4137
20505094	628	643	alpha-synuclein	Gene	6622
20505094	820	822	AD	Disease	MESH:D000544
20505094	827	852	dementia with Lewy bodies	Disease	MESH:D020961
20505094	854	857	DLB	Disease	MESH:D020961
20505094	905	910	human	Species	9606
20505094	911	926	alpha-synuclein	Gene	6622
20505094	947	949	AD	Disease	MESH:D000544
20505094	950	954	mice	Species	10090
20505094	969	974	human	Species	9606
20505094	995	999	mice	Species	10090
20505094	1018	1021	DLB	Disease	MESH:D020961
20505094	1026	1028	AD	Disease	MESH:D000544
20505094	1042	1045	DLB	Disease	MESH:D020961
20505094	1046	1048	AD	Disease	MESH:D000544
20505094	1049	1053	mice	Species	10090
20505094	1075	1092	cognitive decline	Disease	MESH:D003072
20505094	1135	1140	Abeta	Gene	11820
20505094	1142	1145	tau	Gene	4137
20505094	1151	1166	alpha-synuclein	Gene	20617
20505094	1251	1266	alpha-synuclein	Gene	20617
20505094	1353	1358	Abeta	Gene	351
20505094	1360	1363	tau	Gene	4137
20505094	1369	1384	alpha-synuclein	Gene	6622
20505094	1475	1496	cognitive dysfunction	Disease	MESH:D003072
20505094	Association	MESH:D003072	20617
20505094	Positive_Correlation	MESH:D003072	11820
20505094	Association	MESH:D003072	351
20505094	Association	MESH:D000544	351
20505094	Association	MESH:D020961	6622
20505094	Positive_Correlation	MESH:D003072	4137
20505094	Positive_Correlation	MESH:D020961	11820
20505094	Association	MESH:D000544	4137
20505094	Association	MESH:D003072	6622
20505094	Association	MESH:D000544	6622
20505094	Positive_Correlation	MESH:D020961	4137
20505094	Association	MESH:D000544	20617
20505094	Association	MESH:D055956	4137
20505094	Positive_Correlation	MESH:D000544	11820
20505094	Association	MESH:D020961	20617

